Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BeiGene, Ltd. | SVP, General Counsel | Ordinary Shares | 237K | $49.3M | $207.72 | Sep 30, 2024 | Direct |
BeiGene, Ltd. | SVP, General Counsel | American Depositary Shares | 0 | $0 | $237.10 | Sep 30, 2024 | Direct |
BeiGene, Ltd. | SVP, General Counsel | Share Option (Right to Buy) | 185K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BGNE | BeiGene, Ltd. | Sep 30, 2024 | 1 | -$285K | 4 | Oct 2, 2024 | SVP, General Counsel |
BGNE | BeiGene, Ltd. | Jul 30, 2024 | 1 | -$134K | 4 | Aug 1, 2024 | SVP, General Counsel |
BGNE | BeiGene, Ltd. | Jun 17, 2024 | 3 | -$70K | 4 | Jun 20, 2024 | SVP, General Counsel |
BGNE | BeiGene, Ltd. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | SVP, General Counsel |
BGNE | BeiGene, Ltd. | Jul 31, 2023 | 1 | -$171K | 4 | Aug 2, 2023 | SVP, General Counsel |
BGNE | BeiGene, Ltd. | Jun 15, 2023 | 2 | $0 | 4 | Jun 20, 2023 | SVP, General Counsel |
BGNE | BeiGene, Ltd. | Jun 15, 2023 | 0 | $0 | 3 | Jun 20, 2023 | SVP, General Counsel |